Pancreatitis in acute promyelocytic leukemia: Drug-induced or differentiation syndrome?

Acute promyelocytic leukemia (APL) constitutes about 15% of all acute myeloid leukemia patients and can now be treated even without any chemotherapy, with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO). Acute pancreatitis (AP) is a rare adverse event in APL, which is primarily reported to...

全面介紹

書目詳細資料

發表在:	Indian Journal of Medical and Paediatric Oncology
Main Authors:	Dibyendu De, Uttam Kumar Nath, Prantar Chakrabarti
格式:	Article
語言:	英语
出版:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2017-01-01
主題:	Acute promyelocytic leukemia all-trans-retinoic acid arsenic differentiation syndrome pancreatitis
在線閱讀:	http://www.ijmpo.org/article.asp?issn=0971-5851;year=2017;volume=38;issue=3;spage=371;epage=373;aulast=De